San Francisco–based Ossium Health has carried out three transplants for cancer patients using stem cells from deceased donors ...
GlobalData on MSN22h
Syros stock craters after lead cancer therapy flops in Phase III trialThe company plans to discontinue the study after the combination therapy failed to meet the primary endpoint in the Phase III ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback